Edwards Lifesciences Corp. of Irvine said Monday that nearly two-thirds of high-risk patients who received its less-invasive heart valve remained alive two years after treatment. Edwards, a maker of ...
CHICAGO, Sept 21 (Reuters) - Nearly two-thirds of high-risk patients who received an Edwards Lifesciences Corp aortic heart valve through a less-invasive procedure were alive two years after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results